Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo
Conditions: Vertigo; Autonomic Dysfunction Interventions: Drug: Buspirone; Drug: Placebo Sponsor: Valenta Pharm JSC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2022 Category: Research Source Type: clinical trials
